ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2023

Dapagliflozin Improves Erythropoiesis and Iron Metabolism in Type 2 Diabetic Patients with Renal Anemia.

Takeshi Osonoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.